Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Twelve-month, multicenter, intra-subject controlled (retrospective-prospective), open-label,
active-treatment study to evaluate the dose-response and pharmacokinetics (PK) of cinacalcet
HCl for the treatment of Secondary Hyperparathyroidism (SHPT) in paediatric subjects with
chronic kidney disease (CKD) on dialysis, followed by 12-month study extension.